Democratic states petition FDA to lift restrictions on abortion medication mifepristone, citing its safety record and arguing current regulations are medically unnecessary.
Ciena's Q2 2025 results show revenue growth but earnings miss, as demand from cloud and AI sectors offsets margin pressures.
Democratic states petition FDA to lift restrictions on abortion medication mifepristone, citing its safety record and arguing current regulations are medically unnecessary.
Ciena's Q2 2025 results show revenue growth but earnings miss, as demand from cloud and AI sectors offsets margin pressures.
We use cookies to personalize content and ads, to provide social media features, and to analyze our traffic. We also share information about your use of our site with our social media, advertising, and analytics partners.
By continuing to use our site, you consent to our cookies. You can manage your preferences or withdraw your consent at any time by clicking on the buttons below.